Related references
Note: Only part of the references are listed.Phenotypic and genetic characterization of macrolide resistance in Francisella tularensis subsp. holarctica biovar I
Brieuc Gestin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Identification of ciprofloxacin resistance by SimpleProbe™, High Resolution Melt and Pyrosequencing™ nucleic acid analysis in biothreat agents: Bacillus anthracis, Yersinia pestis and Francisella tularensis
Bonnie M. Loveless et al.
MOLECULAR AND CELLULAR PROBES (2010)
Type IIA topoisomerase inhibition by a new class of antibacterial agents
Benjamin D. Bax et al.
NATURE (2010)
Reintroduction of Two Deleted Virulence Loci Restores Full Virulence to the Live Vaccine Strain of Francisella tularensis
Emelie Salomonsson et al.
INFECTION AND IMMUNITY (2009)
Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila
Iyad Almahmoud et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases
Ivan Laponogov et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Simultaneous Detection of CDC Category A DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays
Jie He et al.
VIRUSES-BASEL (2009)
In vitro susceptibility of isolates of Francisella tularensis types A and B from North America
Sandra K. Urich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Tularemia: current diagnosis and treatment options
Matthew J. Hepburn et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
The AcrAB RND efflux system from the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice
Xiaowen R. Bina et al.
FEMS MICROBIOLOGY LETTERS (2008)
Rapid comparative genomic analysis for clinical microbiology:: The Francisella tularensis paradigm
Bernard La Scola et al.
GENOME RESEARCH (2008)
Resistance mechanisms of multiresistant pseudomonas aeruginosa strains from Germany and correlation with Hypermutationdel
B. Henrichfreise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The identification and evaluation of ATP binding cassette systems in the intracellular bacterium Francisella tularensis
Helen S. Atkins et al.
RESEARCH IN MICROBIOLOGY (2006)
Darwinian evolution can follow only very few mutational paths to fitter proteins
DM Weinreich et al.
SCIENCE (2006)
Mechanisms of resistance to quinolones
GA Jacoby
CLINICAL INFECTIOUS DISEASES (2005)
The quinolones: Past, present, and future
VT Andriole
CLINICAL INFECTIOUS DISEASES (2005)
Mechanisms of quinolone resistance in Escherichia coli and Salmonella:: Recent developments
KL Hopkins et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Alterations in the GyrA and GyrB Subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa
JK Lee et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Efflux-mediated antibiotics resistance in bacteria
V Cattoir
PATHOLOGIE BIOLOGIE (2004)
SWISS-MODEL: an automated protein homology-modeling server
T Schwede et al.
NUCLEIC ACIDS RESEARCH (2003)
In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis
A Johansson et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2002)
Patients' stories as narrative
WJ Donnelly
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Ciprofloxacin for treatment of tularemia
A Johansson et al.
CLINICAL INFECTIOUS DISEASES (2001)
NPS@:: Network Protein Sequence Analysis
C Combet et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Share Paper
